Ted M. Ross

Publications

• Delta Inulin-derived Adjuvants That Elicit Th1 Phenotype Following Vaccination Reduces Respiratory Syncytial Virus Lung Titers Without a Reduction in Lung Immunopathology
  Human Vaccines & Immunotherapeutics. May, 2016  |   Pubmed ID: 27215855
• Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses
  Journal of Virology. May, 2016  |   Pubmed ID: 26912624
• Are Plasma Mineral Levels Related to Antibody Response to Influenza Vaccination in Older Adults?
  Human Vaccines & Immunotherapeutics. Apr, 2016  |   Pubmed ID: 26751915
• Use of Computational and Recombinant Technologies for Developing Novel Influenza Vaccines
  Expert Review of Vaccines. 2016  |   Pubmed ID: 26595182
• Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies
  Journal of Virology. Jan, 2016  |   Pubmed ID: 26559834
• Portrait of Dr. Ted M. Ross
  Human Vaccines & Immunotherapeutics. Mar, 2016  |   Pubmed ID: 26552916
• Emerging Infections of CNS: Avian Influenza A Virus, Rift Valley Fever Virus and Human Parechovirus
  Brain Pathology (Zurich, Switzerland). Sep, 2015  |   Pubmed ID: 26276027
• Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist As Adjuvant
  Journal of Virology. Oct, 2015  |   Pubmed ID: 26269188
• Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift During the 2014-2015 Influenza Season
  Cell Reports. Jul, 2015  |   Pubmed ID: 26119736
• The Inflammatory Response to Influenza A Virus (H1N1): An Experimental and Mathematical Study
  Journal of Theoretical Biology. Jun, 2015  |   Pubmed ID: 25843213
• Cocktail of H5N1 COBRA HA Vaccines Elicit Protective Antibodies Against H5N1 Viruses from Multiple Clades
  Human Vaccines & Immunotherapeutics. 2015  |   Pubmed ID: 25671661
• Randomized, Controlled Trial of High-dose Influenza Vaccine Among Frail Residents of Long-term Care Facilities
  The Journal of Infectious Diseases. Jun, 2015  |   Pubmed ID: 25525051
• Cross-protection Against H7N9 Influenza Strains Using a Live-attenuated H7N3 Virus Vaccine
  Vaccine. Jan, 2015  |   Pubmed ID: 25448100
• C3d Adjuvant Effects Are Mediated Through the Activation of C3d-specific Autoreactive T Cells
  Immunology and Cell Biology. Feb, 2015  |   Pubmed ID: 25385064
• Potential Antigenic Explanation for Atypical H1N1 Infections Among Middle-aged Adults During the 2013-2014 Influenza Season
  Proceedings of the National Academy of Sciences of the United States of America. Nov, 2014  |   Pubmed ID: 25331901
• H5 N-terminal β Sheet Promotes Oligomerization of H7-HA1 That Induces Better Antibody Affinity Maturation and Enhanced Protection Against H7N7 and H7N9 Viruses Compared to Inactivated Influenza Vaccine
  Vaccine. Nov, 2014  |   Pubmed ID: 25284811
• Challenges and Future in Vaccines, Drug Development, and Immunomodulatory Therapy
  Annals of the American Thoracic Society. Aug, 2014  |   Pubmed ID: 25148426
• A Polyvalent Clade B Virus-like Particle HIV Vaccine Combined with Partially Protective Oral Preexposure Prophylaxis Prevents Simian-human Immunodeficiency Virus Infection in Macaques and Primes for Virus-amplified Immunity
  AIDS Research and Human Retroviruses. Nov, 2014  |   Pubmed ID: 24914761
• Use of Transmission Electron Microscopy to Identify Nanocrystals of Challenging Protein Targets
  Proceedings of the National Academy of Sciences of the United States of America. Jun, 2014  |   Pubmed ID: 24872454
• Influenza Virus Infection Elicits Protective Antibodies and T Cells Specific for Host Cell Antigens Also Expressed As Tumor-associated Antigens: a New View of Cancer Immunosurveillance
  Cancer Immunology Research. Mar, 2014  |   Pubmed ID: 24778322
• Eliciting Broadly Protective Antibody Responses Against Influenza
  Current Opinion in Immunology. Jun, 2014  |   Pubmed ID: 24632083
• Influence of Pre-existing Hemagglutination Inhibition Titers Against Historical Influenza Strains on Antibody Response to Inactivated Trivalent Influenza Vaccine in Adults 50-80 Years of Age
  Human Vaccines & Immunotherapeutics. 2014  |   Pubmed ID: 24614078
• Cross-conservation of T-cell Epitopes: Now Even More Relevant to (H7N9) Influenza Vaccine Design
  Human Vaccines & Immunotherapeutics. 2014  |   Pubmed ID: 24525618
• Effects of Aging on Influenza Virus Infection Dynamics
  Journal of Virology. Apr, 2014  |   Pubmed ID: 24478442
• Massive Mobilization of Dendritic Cells During Influenza A Virus Subtype H5N1 Infection of Nonhuman Primates
  The Journal of Infectious Diseases. Jun, 2014  |   Pubmed ID: 24403559
• H1N1, but Not H3N2, Influenza A Virus Infection Protects Ferrets from H5N1 Encephalitis
  Journal of Virology. Mar, 2014  |   Pubmed ID: 24371072
• Mucosal Pre-exposure to Th17-inducing Adjuvants Exacerbates Pathology After Influenza Infection
  The American Journal of Pathology. Jan, 2014  |   Pubmed ID: 24183780
• A Novel Outbred Mouse Model of 2009 Pandemic Influenza and Bacterial Co-infection Severity
  PloS One. 2013  |   Pubmed ID: 24324838
• A Novel Nonhuman Primate Model for Influenza Transmission
  PloS One. 2013  |   Pubmed ID: 24244352
• Immunization with Cross-conserved H1N1 Influenza CD4+ T-cell Epitopes Lowers Viral Burden in HLA DR3 Transgenic Mice
  Human Vaccines & Immunotherapeutics. Oct, 2013  |   Pubmed ID: 24045788
• Immune History Shapes Specificity of Pandemic H1N1 Influenza Antibody Responses
  The Journal of Experimental Medicine. Jul, 2013  |   Pubmed ID: 23857983
• Intranasal Antibody Gene Transfer in Mice and Ferrets Elicits Broad Protection Against Pandemic Influenza
  Science Translational Medicine. May, 2013  |   Pubmed ID: 23720583
• Rhesus Macaques Vaccinated with Consensus Envelopes Elicit Partially Protective Immune Responses Against SHIV SF162p4 Challenge
  Virology Journal. 2013  |   Pubmed ID: 23548077
• Sequencing, Annotation, and Characterization of the Influenza Ferret Infectome
  Journal of Virology. Feb, 2013  |   Pubmed ID: 23236062
• Sequential Seasonal H1N1 Influenza Virus Infections Protect Ferrets Against Novel 2009 H1N1 Influenza Virus
  Journal of Virology. Feb, 2013  |   Pubmed ID: 23115287
• Oligomeric Recombinant H5 HA1 Vaccine Produced in Bacteria Protects Ferrets from Homologous and Heterologous Wild-type H5N1 Influenza Challenge and Controls Viral Loads Better Than Subunit H5N1 Vaccine by Eliciting High-affinity Antibodies
  Journal of Virology. Nov, 2012  |   Pubmed ID: 22951833
• Complex Patterns of Human Antisera Reactivity to Novel 2009 H1N1 and Historical H1N1 Influenza Strains
  PloS One. 2012  |   Pubmed ID: 22815705
• A Computationally Optimized Hemagglutinin Virus-like Particle Vaccine Elicits Broadly Reactive Antibodies That Protect Nonhuman Primates from H5N1 Infection
  The Journal of Infectious Diseases. May, 2012  |   Pubmed ID: 22448011
• Plasmacytoid Dendritic Cell Depletion Leads to an Enhanced Mononuclear Phagocyte Response in Lungs of Mice with Lethal Influenza Virus Infection
  Comparative Immunology, Microbiology and Infectious Diseases. Jul, 2012  |   Pubmed ID: 22421538
• Computationally Optimized Antigens to Overcome Influenza Viral Diversity
  Expert Review of Vaccines. Mar, 2012  |   Pubmed ID: 22380818
• Influenza Virus H1N1pdm09 Infections in the Young and Old: Evidence of Greater Antibody Diversity and Affinity for the Hemagglutinin Globular Head Domain (HA1 Domain) in the Elderly Than in Young Adults and Children
  Journal of Virology. May, 2012  |   Pubmed ID: 22379097
• Evaluation of Heterologous Vaginal SHIV SF162p4 Infection Following Vaccination with a Polyvalent Clade B Virus-like Particle Vaccine
  AIDS Research and Human Retroviruses. Sep, 2012  |   Pubmed ID: 22214267
• Antibody Breadth and Protective Efficacy Are Increased by Vaccination with Computationally Optimized Hemagglutinin but Not with Polyvalent Hemagglutinin-based H5N1 Virus-like Particle Vaccines
  Clinical and Vaccine Immunology : CVI. Feb, 2012  |   Pubmed ID: 22190399
• Elicitation of Anti-1918 Influenza Virus Immunity Early in Life Prevents Morbidity and Lower Levels of Lung Infection by 2009 Pandemic H1N1 Influenza Virus in Aged Mice
  Journal of Virology. Feb, 2012  |   Pubmed ID: 22130546
• Absence of Fetal Transmission of H1N1 Despite Severe Maternal Infection
  Influenza and Other Respiratory Viruses. May, 2012  |   Pubmed ID: 22103260
• Animal Models of Rift Valley Fever Virus Infection
  Virus Research. Feb, 2012  |   Pubmed ID: 22086058
• Acute Murine H5N1 Influenza A Encephalitis
  Brain Pathology (Zurich, Switzerland). Mar, 2012  |   Pubmed ID: 21714828
• Prevalence of Antibodies Against Seasonal Influenza A and B Viruses During the 2009-2010 and 2010-2011 Influenza Seasons in Residents of Pittsburgh, PA, USA
  PLoS Currents. 2011  |   Pubmed ID: 22037352
• Adjuvants That Stimulate TLR3 or NLPR3 Pathways Enhance the Efficiency of Influenza Virus-like Particle Vaccines in Aged Mice
  Vaccine. Nov, 2011  |   Pubmed ID: 21963872
• Baculovirus-produced Influenza Virus-like Particles in Mammalian Cells Protect Mice from Lethal Influenza Challenge
  Viral Immunology. Aug, 2011  |   Pubmed ID: 21830902
• Comparaison à Grande échelle Des Réponses Innées De Pathogènes Virus Et Bactériens Dans La Souris Et Le Macaque
  PloS One. 2011  |   Pubmed ID: 21789257
• An Agent-based Model of Inflammation and Fibrosis Following Particulate Exposure in the Lung
  Mathematical Biosciences. Jun, 2011  |   Pubmed ID: 21385589
• A Computationally Optimized Broadly Reactive Antigen (COBRA) Based H5N1 VLP Vaccine Elicits Broadly Reactive Antibodies in Mice and Ferrets
  Vaccine. Apr, 2011  |   Pubmed ID: 21320540
• Challenges in Improving Influenza Vaccine Protection in the Elderly
  Expert Review of Vaccines. Jan, 2011  |   Pubmed ID: 21162614
• Vaccination of Patients with Mild and Severe Asthma with a 2009 Pandemic H1N1 Influenza Virus Vaccine
  The Journal of Allergy and Clinical Immunology. Jan, 2011  |   Pubmed ID: 21145578
• Bacterial HA1 Vaccine Against Pandemic H5N1 Influenza Virus: Evidence of Oligomerization, Hemagglutination, and Cross-protective Immunity in Ferrets
  Journal of Virology. Feb, 2011  |   Pubmed ID: 21084473
• Hemagglutinin Displayed Baculovirus Protects Against Highly Pathogenic Influenza
  Vaccine. Oct, 2010  |   Pubmed ID: 20727393
• Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza in Pittsburgh, PA, USA
  PloS One. 2010  |   Pubmed ID: 20644650
• Properly Folded Bacterially Expressed H1N1 Hemagglutinin Globular Head and Ectodomain Vaccines Protect Ferrets Against H1N1 Pandemic Influenza Virus
  PloS One. 2010  |   Pubmed ID: 20634959
• Vaccination with DNA Plasmids Expressing Gn Coupled to C3d or Alphavirus Replicons Expressing Gn Protects Mice Against Rift Valley Fever Virus
  PLoS Neglected Tropical Diseases. 2010  |   Pubmed ID: 20582312
• Dengue Virus
  Clinics in Laboratory Medicine. Mar, 2010  |   Pubmed ID: 20513545
• West Nile Virus
  Clinics in Laboratory Medicine. Mar, 2010  |   Pubmed ID: 20513541
• Enhancement of Anti-DIII Antibodies by the C3d Derivative P28 Results in Lower Viral Titers and Augments Protection in Mice
  Virology Journal. 2010  |   Pubmed ID: 20462412
• Modeling Host Responses in Ferrets During A/California/07/2009 Influenza Infection
  Virology. Jun, 2010  |   Pubmed ID: 20334888
• Animal Lentiviruses. Editorial
  Current HIV Research. Jan, 2010  |   Pubmed ID: 20238449
• C3d Adjuvant Activity is Reduced by Altering Residues Involved in the Electronegative Binding of C3d to CR2
  Immunology Letters. Mar, 2010  |   Pubmed ID: 20064559
• Impaired Immune Responses in the Lungs of Aged Mice Following Influenza Infection
  Respiratory Research. 2009  |   Pubmed ID: 19922665
• Critical Role of IL-17RA in Immunopathology of Influenza Infection
  Journal of Immunology (Baltimore, Md. : 1950). Oct, 2009  |   Pubmed ID: 19783685
• A Trivalent Virus-like Particle Vaccine Elicits Protective Immune Responses Against Seasonal Influenza Strains in Mice and Ferrets
  PloS One. 2009  |   Pubmed ID: 19554101
• Human Immunodeficiency Virus-like Particles with Consensus Envelopes Elicited Broader Cell-mediated Peripheral and Mucosal Immune Responses Than Polyvalent and Monovalent Env Vaccines
  Vaccine. Jul, 2009  |   Pubmed ID: 19389453
• The Role of RNA Folding Free Energy in the Evolution of the Polymerase Genes of the Influenza A Virus
  Genome Biology. 2009  |   Pubmed ID: 19216739
• Simian Immunodeficiency Virus Pathogenesis
  Current HIV Research. Jan, 2009  |   Pubmed ID: 19149548
• Viral Sequence Diversity: Challenges for AIDS Vaccine Designs
  Expert Review of Vaccines. Nov, 2008  |   Pubmed ID: 18980542
• Elicitation of Protective Immune Responses Using a Bivalent H5N1 VLP Vaccine
  Virology Journal. 2008  |   Pubmed ID: 18957098
• Épitope Vaccin à ADN Contenant Le Composant Complément C3d Améliore La Production D'anticorps Anti-amyloid-beta Et Polarise La Réponse Immunitaire Vers Un Phénotype Th2
  Journal of Neuroimmunology. Dec, 2008  |   Pubmed ID: 18838175
• H5N1 VLP Vaccine Induced Protection in Ferrets Against Lethal Challenge with Highly Pathogenic H5N1 Influenza Viruses
  Vaccine. Oct, 2008  |   Pubmed ID: 18706956
• A Bivalent Influenza VLP Vaccine Confers Complete Inhibition of Virus Replication in Lungs
  Vaccine. Jun, 2008  |   Pubmed ID: 18468740
• HIV Genes Diversify in B Cells
  Current HIV Research. Jan, 2008  |   Pubmed ID: 18288970
• Cross-clade Protective Immune Responses to Influenza Viruses with H5N1 HA and NA Elicited by an Influenza Virus-like Particle
  PloS One. 2008  |   Pubmed ID: 18231588
• Patch Adjuvant Immunostimulant Améliore Des Réponses Immunitaires Humorales Et Cellulaires à L'immunisation De L'ADN
  DNA and Cell Biology. Jan, 2008  |   Pubmed ID: 17961074
• Antibody Neutralization
  Current HIV Research. Nov, 2007  |   Pubmed ID: 18045107
• Mucosal Vaccine Vectors: Replication-competent Versus Replication-deficient Poxviruses
  Current Pharmaceutical Design. 2007  |   Pubmed ID: 17627535
• Developing Broadly Reactive HIV-1/AIDS Vaccines: a Review of Polyvalent and Centralized HIV-1 Vaccines
  Current Pharmaceutical Design. 2007  |   Pubmed ID: 17627529
• Reduction of Anti-HIV-1 Gag Immune Responses During Co-immunization: Immune Interference by the HIV-1 Envelope
  Current HIV Research. Mar, 2007  |   Pubmed ID: 17346134
• Influenza Virus-like Particles Elicit Broader Immune Responses Than Whole Virion Inactivated Influenza Virus or Recombinant Hemagglutinin
  Vaccine. May, 2007  |   Pubmed ID: 17337102
• Membrane Embedded HIV-1 Envelope on the Surface of a Virus-like Particle Elicits Broader Immune Responses Than Soluble Envelopes
  Virology. Feb, 2007  |   Pubmed ID: 17011011
• Complement-mediated Activation of the Adaptive Immune Responses: Role of C3d in Linking the Innate and Adaptive Immunity
  Immunologic Research. 2006  |   Pubmed ID: 17337780
• Lentivirus-like Particles Without Reverse Transcriptase Elicit Efficient Immune Responses
  Current HIV Research. Oct, 2006  |   Pubmed ID: 17073623
• Virus-like Particles: Designing an Effective AIDS Vaccine
  Methods (San Diego, Calif.). Sep, 2006  |   Pubmed ID: 16997718
• A Minimum CR2 Binding Domain of C3d Enhances Immunity Following Vaccination
  Advances in Experimental Medicine and Biology. 2006  |   Pubmed ID: 16893077
• HIV-1 Envgp140 Trimers Elicit Neutralizing Antibodies Without Efficient Induction of Conformational Antibodies
  Vaccine. Jun, 2006  |   Pubmed ID: 16621193
• Elicitation of Immunity to HIV Type 1 Gag is Determined by Gag Structure
  AIDS Research and Human Retroviruses. Jan, 2006  |   Pubmed ID: 16438652
• C3d Enhances Immune Responses Using Low Doses of DNA Expressing the HIV-1 Envelope from Codon-optimized Gene Sequences
  Current HIV Research. Apr, 2005  |   Pubmed ID: 15853723
• Unique V3 Loop Sequence Derived from the R2 Strain of HIV-type 1 Elicits Broad Neutralizing Antibodies
  AIDS Research and Human Retroviruses. Nov, 2004  |   Pubmed ID: 15588348
• Multiple Residues in the Extracellular Domains of CCR3 Are Critical for Coreceptor Activity
  Virology. Nov, 2004  |   Pubmed ID: 15476879
• DNA Vaccines Expressing Soluble CD4-envelope Proteins Fused to C3d Elicit Cross-reactive Neutralizing Antibodies to HIV-1
  Virology. Oct, 2004  |   Pubmed ID: 15464849
• Characterization of a DNA Vaccine Expressing a Human Immunodeficiency Virus-like Particle
  Virology. Oct, 2004  |   Pubmed ID: 15351214
• Cutting Edge: C3d Functions As a Molecular Adjuvant in the Absence of CD21/35 Expression
  Journal of Immunology (Baltimore, Md. : 1950). May, 2004  |   Pubmed ID: 15128761
• Elicitation of Neutralizing Antibodies with DNA Vaccines Expressing Soluble Stabilized Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trimers Conjugated to C3d
  Journal of Virology. May, 2004  |   Pubmed ID: 15078953
• Mouse Strain-dependent Differences in Enhancement of Immune Responses by C3d
  Vaccine. Apr, 2004  |   Pubmed ID: 15068861
• Independent but Not Synergistic Enhancement to the Immunogenicity of DNA Vaccine Expressing HIV-1 Gp120 Glycoprotein by Codon Optimization and C3d Fusion in a Mouse Model
  Vaccine. Apr, 2004  |   Pubmed ID: 15068860
• Génération Et Caractérisation De La Réponse Immunitaire Humorale à L'immunisation De L'ADN Avec Un Minigène Chimérique De Bêta-amyloïde-interleukine-4
  European Journal of Immunology. Dec, 2003  |   Pubmed ID: 14635031
• Protection Against Influenza Virus Infection by Intranasal Administration of C3d-fused Hemagglutinin
  Vaccine. Nov, 2003  |   Pubmed ID: 14575764
• Particle-based Vaccines for HIV-1 Infection
  Current Drug Targets. Infectious Disorders. Jun, 2003  |   Pubmed ID: 12769792
• Impact of Glycosylation on the Immunogenicity of a DNA-based Influenza H5 HA Vaccine
  Virology. Apr, 2003  |   Pubmed ID: 12706077
• Induction of Heterosubtypic Immunity to Influenza A Virus Using a DNA Vaccine Expressing Hemagglutinin-C3d Fusion Proteins
  Vaccine. Feb, 2003  |   Pubmed ID: 12547601
• Enhancement of Antibodies to the Human Immunodeficiency Virus Type 1 Envelope by Using the Molecular Adjuvant C3d
  Journal of Virology. Feb, 2003  |   Pubmed ID: 12525639